Jun Luo

16PUBLICATIONS
117CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsBiomaterialsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 05, 2026
Germline genetic risk and prostate cancer-specific mortality in a population-based incident cohort.

|May 26, 2026
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer.

|Apr 29, 2026
Evaluation of Tissue from Patients with Prostate Cancer Identifies B7-H3 as an Androgen-Regulated, Broadly Expressed, Combinatorial Therapeutic Target.

|Apr 01, 2026
Cytoplasmic versus nuclear localization of androgen receptor splice variant 7 as a predictor of benefit from androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (PROPHECY trial).

Santosh Gupta, Siyuan Guo, Susan Halabi

|Jun 20, 2025
Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variant.

Mayuko Kanayama, Emeline Colomba, Yusra Shao

|Jan 28, 2025
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptor.

Rajendra Kumar, Janet Mendonca, Abhishek Shetty

Pageof 3

Frequent Collaborators

5 joint publications

Emmanuel S Antonarakis

3 joint publications

Susan Halabi

3 joint publications

Daniel Costin Danila

3 joint publications

Changxue Lu